Drug treatment of neuropathic pain
- Robert D Helme
- Aust Prescr 2006;29:82
- 1 June 2006
- DOI: 10.18773/austprescr.2006.050
The most common cause of intraoral pain in patients presenting to dentists is odontogenic and rarely presents a diagnostic challenge. However, pain in the oral cavity that is not dental or periodontal in origin may be difficult to diagnose and treat.
Neuropathic pain in the orofacial region, such as post-herpetic neuralgia, post-traumatic painful peripheral neuropathy ('phantom tooth pain'), idiopathic trigeminal neuralgia (tic douloureux), or chronic orofacial pain ('atypical odontalgia') can be defined as pain initiated or caused by a primary lesion or dysfunction in the nervous system. The presentation of neuropathic pain in and around the mouth has been extensively reviewed.1,2,3
If neuropathic pain is suspected a thorough clinical evaluation is necessary to assess this type of pain and its mechanism. Dental treatments that are irreversible and potentially harmful to the underlying dentoalveolar structures must be avoided when the diagnosis is uncertain.
Dentists are often asked to exclude the likelihood of pain of odontogenic origin contributing to neuropathic pain. They need to be aware of the drugs patients may be taking as well as making themselves available to assist in the management of these patients within multidisciplinary pain clinics.
Professor, Department of Medicine, Royal Melbourne Hospital, University of Melbourne
Director, Department of Neurology, Western Health, Melbourne